Research Overview
Across the provided abstracts, lanolin appears primarily in dermatologic contexts rather than as a primary therapeutic agent under investigation. The most studied areas represented here are (1) scar management after burns, where “lanolin massage” is used as a comparator or co-intervention in trials of pressure-garment therapy (PGT), and (2) xerosis (dry skin) management in older adults, where lanolin is discussed mainly as a potential sensitizer in emollient products. A separate abstract mentions “lanolin ester alcohol” in relation to astragaloside IV’s chemical form, but this is a structural/chemical description rather than evidence about lanolin’s clinical effects.
The strongest evidence in these abstracts does not establish lanolin as an effective treatment for scarring; instead, the Cochrane review indicates that evidence is very uncertain regarding whether PGT improves hypertrophic scarring compared with no treatment/lanolin, and similarly uncertain across comparisons involving silicone and other scar therapies. Thus, within burn-scar prevention/treatment research, lanolin’s role is largely that of a control condition and the current randomized evidence base does not allow firm conclusions about relative benefits or harms. In xerosis guidance for older adults, the most defensible conclusion supported here is cautionary: lanolin is identified as a common ingredient that can act as a skin sensitizer capable of triggering delayed hypersensitivity (allergic contact dermatitis) in some individuals, implying that avoidance may be prudent in patients with suspected or known sensitivity.
Key gaps include a lack of high-certainty, lanolin-focused clinical trials that isolate lanolin’s effects (e.g., lanolin versus other emollients or placebo) on clinically meaningful outcomes such as barrier function, pruritus reduction, infection risk, and quality of life in xerosis and dermatitis-prone populations. In burn and scar care, future studies would need longer follow-up (given scar maturation timelines), standardized outcome measures (e.g., POSAS/VSS with consistent reporting), and clearer separation of co-interventions to determine whether lanolin massage has independent benefit or risk. Additional research is also needed to quantify sensitization prevalence and risk factors (especially in atopic individuals and children) and to distinguish reactions to lanolin itself versus impurities or specific lanolin derivatives used in topical formulations.
1. What conditions has Lanolin been studied for?
Burn-related hypertrophic scarring (scar prevention/management): Lanolin massage was used as a comparator or co-intervention in randomized trials of pressure-garment therapy (PGT) after burn injury (e.g., “no treatment/lanolin” control conditions).
Painful nipples during breastfeeding: Lanolin (alone and with breast shells) was evaluated as a topical treatment in randomized or quasi-randomized trials included in a Cochrane review of interventions for nipple pain.
Dry skin (xerosis) and pruritus risk in older adults: Lanolin is discussed in a geriatric xerosis review primarily as a potential sensitizer to avoid in emollients, rather than as a proven treatment.
Allergic contact dermatitis (ACD) / contact sensitization, especially in atopic dermatitis (AD): A pediatric patch-test registry study reported increased reactions to lanolin/wool alcohol among children with AD compared with those without AD.
Not a clinical “lanolin supplement” use, but lanolin-related chemistry: One abstract notes Astragaloside IV is “in the form of lanolin ester alcohol,” but the described pharmacologic effects are attributed to Astragaloside IV (a plant saponin), not to lanolin as a treatment.
2. Does it work in treating those conditions? Summarize the evidence.
-
Breastfeeding nipple pain: Evidence does not show lanolin is clearly effective.
In the Cochrane review (4 trials; 656 women), pooled data were available only for lanolin vs usual care.
One trial found no clear differences in nipple pain between applying lanolin and applying nothing at multiple early timepoints (1–3, 4–5, and 6–7 days post-treatment).
The same trial found expressed breast milk led to lower perceived nipple pain than lanolin at 4–5 days, but the benefit was not maintained at 6–7 days.
Glycerine gel dressings and breast shells with lanolin also did not significantly improve nipple pain in the review.
-
Hypertrophic scarring after burns: The evidence does not establish lanolin as an effective scar treatment; rather, lanolin appears mainly as a comparator in PGT trials.
In the 2023 Cochrane review of PGT (15 studies; 1179 participants), comparisons included PGT vs no treatment/lanolin and PGT + silicone vs no treatment/lanolin.
The review concluded the evidence is very uncertain whether PGT improves scars compared with no treatment/lanolin (e.g., Vancouver Scar Scale outcomes), and similarly uncertain for pain, pruritus, adverse events, and adherence.
Because lanolin was part of the “no treatment/lanolin” comparator, these trials do not provide strong direct evidence that lanolin itself improves scarring.
-
Xerosis (dry skin) in older adults: The abstract does not provide efficacy data for lanolin; it specifically advises avoiding lanolin as a potential sensitizer in emollients.
-
Allergic contact dermatitis / sensitization: Patch-test data support that lanolin (wool alcohol) can be a relevant allergen, especially in children with AD; this is evidence of risk rather than treatment benefit.
3. What health benefits does it have?
Potential emollient/moisturizing role (general use): Lanolin is commonly included in skin-care preparations and nipple products, implying intended barrier/emollient benefits; however, the provided abstracts do not demonstrate clear clinical superiority for lanolin in the studied outcomes (e.g., nipple pain).
No proven benefit for nipple pain vs doing nothing: In at least one trial summarized in the breastfeeding pain Cochrane review, lanolin did not clearly reduce pain compared with no topical application.
No proven scar-prevention benefit from the provided evidence: In burn scar management literature summarized, lanolin appears as part of a comparator condition and does not emerge as an evidence-based active therapy from these abstracts.
4. Does it have any downsides or side effects?
-
Allergic contact dermatitis / delayed hypersensitivity:
A geriatric xerosis review advises avoiding common sensitizers in emollients, explicitly including lanolin, because they “may lead to a delayed hypersensitivity reaction.”
In a pediatric patch-test registry study (1142 children), those with atopic dermatitis had an increased frequency of reactions to wool alcohol/lanolin compared with those without AD, indicating higher sensitization risk in this population.
Potential tolerability/adherence issues in scar care contexts: In the burn PGT Cochrane review, adverse events and adherence were key outcomes, but evidence was “very uncertain” across comparisons that sometimes used lanolin in control arms; the abstracts do not isolate lanolin-specific adverse event rates.
5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?
The provided abstracts do not report pharmacogenomic findings for lanolin (no gene–lanolin interactions, genotype-stratified outcomes, or genetic predictors of response/adverse effects).
Indirect relevance only: The pediatric registry reports higher odds of concomitant AD in Asian and African American children and higher lanolin/wool alcohol reaction frequency in children with AD, but this is not a genetic-variant (pharmacogenomic) analysis and does not identify specific genotypes.
References
-
Pharmacological Effects of Astragaloside IV: A Review.
Yutong Liang, Biqiong Chen, Di Liang, Xiaoxiao Quan, Ruolan Gu, Zhiyun Meng, Hui Gan, Zhuona Wu, Yunbo Sun, Shuchen Liu, Guifang Dou (2023) - Molecules (Basel, Switzerland) -
Pressure-garment therapy for preventing hypertrophic scarring after burn injury.
Isobel M Harris, Kwang Chear Lee, Jonathan J Deeks, David J Moore, Naiem S Moiemen, Janine Dretzke (2024) - The Cochrane database of systematic reviews -
Dry skin in the elderly: complexities of a common problem.
E Foy White-Chu, Madhuri Reddy (2011) - Clinics in dermatology -
Pediatric Contact Dermatitis Registry Data on Contact Allergy in Children With Atopic Dermatitis.
Sharon E Jacob, Maria McGowan, Nanette B Silverberg, Janice L Pelletier, Luz Fonacier, Nico Mousdicas, Doug Powell, Andrew Scheman, Alina Goldenberg (2017) - JAMA dermatology -
Interventions for treating painful nipples among breastfeeding women.
Cindy-Lee Dennis, Kim Jackson, Jo Watson (2014) - The Cochrane database of systematic reviews -
Sensitization to Lanolin in North-Eastern Italy, 1997-2021: Prevalence, Risk Factors and the Impact of Occupation
Luca Cegolon, Francesca Larese Filon, On Behalf Of The North-East Research Group On Contact Dermatitis (2024) -
Basic Emollients for Xerosis Cutis in Atopic Dermatitis: A Review of Clinical Studies.
Andreas Wollenberg, Sebastien Barbarot, Antonio Torrelo (2025) - International journal of dermatology -
Effectiveness of the Application of Lanolin, Aloe Vera, and Peppermint on Nipple Pain and Nipple Trauma in Lactating Mothers: A Systematic Review and Meta-Analysis.
Asha P Shetty, Kurvatteppa Halemani, Alwin Issac, Latha Thimmappa, Y N Shashidhara, Edlin Mathias, Sanjay Dhiraaj, K Radha, Prabhaker Mishra, Auchitya Sharma (2024) - Maternal and child health journal -
Basic Emollients for Xerosis Cutis Not Associated With Atopic Dermatitis: A Review of Clinical Studies.
Jacek C Szepietowski, Gianluca Tadini (2025) - International journal of dermatology -
Lanolin for the treatment of nipple pain in breastfeeding women: a randomized controlled trial.
Kimberley T Jackson, Cindy-Lee Dennis (2017) - Maternal & child nutrition -
Effects of four soaps on skin trans-epidermal water loss and erythema index.
Zeynab Khosrowpour, Saman Ahmad Nasrollahi, Azin Ayatollahi, Aniseh Samadi, Alireza Firooz (2019) - Journal of cosmetic dermatology -
Positive effect of HPA lanolin versus expressed breastmilk on painful and damaged nipples during lactation.
M Abou-Dakn, J W Fluhr, M Gensch, A Wöckel (2011) - Skin pharmacology and physiology -
Pre-Emptive Avoidance Strategy (P.E.A.S.) - addressing allergic contact dermatitis in pediatric populations.
Hannah Hill, Alina Goldenberg, Linda Golkar, Kristyn Beck, Judith Williams, Sharon E Jacob (2016) - Expert review of clinical immunology -
Contact Allergens in Prescription Topical Ophthalmic Medications.
Rob L Shaver, Erin M Warshaw (2022) - Dermatitis : contact, atopic, occupational, drug -
Patch-test results in children and adolescents: systematic review of a 15-year period.
Dulcilea Ferraz Rodrigues, Eugênio Marcos Andrade Goulart (2016) - Anais brasileiros de dermatologia -
A systematic review of the interventions for nipple trauma in breastfeeding mothers.
Flaviana Vieira, Maria Márcia Bachion, Dálete Delalibera C F Mota, Denize Bouttelet Munari (2013) - Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing -
An all-purpose nipple ointment versus lanolin in treating painful damaged nipples in breastfeeding women: a randomized controlled trial.
Cindy-Lee Dennis, Nancy Schottle, Ellen Hodnett, Karen McQueen (2012) - Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine -
Allergic Contact Dermatitis to Operating Room Scrubs and Disinfectants.
Jamie P Schlarbaum, Sara A Hylwa (2019) - Dermatitis : contact, atopic, occupational, drug -
The frequency of specific contact allergies is reduced in patients with psoriasis.
A Claßen, T Buhl, S Schubert, M Worm, A Bauer, J Geier, S Molin (2019) - The British journal of dermatology -
Enzymatic synthesis of branched chain fatty acid-enriched structured triacylglycerols via esterification with glycerol.
Yaqi Huang, Houyue Li, Zixin Wang, Yijie Fu, Yang Chen, Xiaosan Wang (2023) - Food chemistry
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!